Lower ratings of pain intensity in older adults lead to underestimation of disease activity in patients with rheumatoid arthritis
Journal Title: International Journal of Clinical Rheumatology - Year 2017, Vol 12, Issue 2
Abstract
Background: To investigate the influence of age on the components of the 28-joint Disease Activity Score (DAS28)-C-Reactive Protein (CRP) in patients with Rheumatoid Arthritis (RA) and whether DAS28-CRP can be equally interpreted in all age groups. Methods: The proportion of CRP and patient reported components of the DAS28 (DAS-P) were analyzed and compared between 2 age groups (younger RA <60, older RA ≥ 60) using Mann-Whitney U test. Inflammatory disease burden in the joint was calculated by modified DAS28 (MDAS28=0.49 x ln(C-Reactive Protein (CRP))+0.15 x swollen joint count 28+0.22 x physician global assessment (PhGA)+1). Multivariate analyses were used to design models best predicting the effect of age on CRP, the proportion of CRP, inflammation level calculated by MDAS28, DAS-P, and pain levels. Results: CRP and the proportion of CRP in DAS28-CRP were not influenced by age. MDAS28 did not increase with age but was associated with disease duration and anti-tumor necrosis factor (TNF) therapy. DAS-P and pain level had significant negative association with age. In subjects with moderate inflammation (defined by MDAS28 score above 50 percentile, N=370), older RA subjects (N=189) had lower pain level, tender joint count, patient and physician global assessment, DAS28-CRP than younger subjects (n=157). Conclusions: CRP, proportion of CRP in DAS28-CRP, and MDAS28 were not influenced by age but the proportion of subjective components of DAS28-CRP and pain level decreased with age. Therefore, disease activity could be underestimated by DAS28-CRP in older RA patients.
Authors and Affiliations
Yong Gil Hwang, Ajay D Wasan, June Feng, Heather Eng, Jason Lyons, Anthony Fabio, Larry W Moreland
Keywords
Related Articles
- EP ID EP603276
- DOI -
- Views 44
- Downloads 0
Rheumatology to hepatology cross talk: An evidence based update on the treat to target strategy in hepatitis-C related extrahepatic autoimmune syndromes
Hepatitis C virus (HCV) is a universally identified major epidemiological health problem with an estimated reservoir of almost 200 million or 3% of the global population. In the year 2013, the WHO declared viral hepatiti...
Improved clinical outcomes and physical activity in patients with rheumatoid arthritis treated with originator adalimumab in routine clinical practice
Background/Objective: We aimed at evaluating changes in habitual physical activity, disease activity and physical function following treatment with originator adalimumab (ADAORIG) in patients with Rheumatoid Arthritis (R...
Predictive value of rheumatoid factor titre in cryoglobulinemia in Hepatitis C positive patients
Background/objective: HCV viremia has been known to provoke a plethora of autoimmune syndromes as well as nonspecific rheumatologic manifestations. HCV is the most frequent cause of mixed cryoglobulinemia, which is chara...
Association of sarcoidosis and psoriasis: a difficult diagnosis
Sarcoidosis is a chronic multisystem disorder characterized by the formation of non caseating epithelioid cell granulomas affecting multiple organ systems. The role of the type 1 helper T (TH1) cells and type 17 helper T...
The test/retest reliability of physical performance measures in osteoarthritis patients
Objectives: There is limited data examining the reliability and consistency of objective measures of osteoarthritis (OA) function. Therefore the aim of this study was to assess their test/retest reliability. Methods: 21...